Archive - AlleyCorp’s Newsletter

AlleyCorp's New $250M Fund

Sharing news about an exciting step for AlleyCorp.

Apr 10 •

January 2024

AlleyCorp in 2023 and Looking Ahead to 2024

Looking back on a transformational year in tech

Jan 11 •

October 2023

AlleyCorp in Q3

Announcing new incubations, investments, and more from AlleyCorp

Oct 12, 2023 •

Introducing AlleyCorp Impact Eng(ine)

We're proud to announce a new effort between AlleyCorp Impact and Engineering.

Oct 9, 2023 •

July 2023

AlleyCorp in Q2

The latest news from AlleyCorp's team and companies

Jul 12, 2023 •

April 2023

AlleyCorp in Q1

New investments, the annual AlleyCorp Impact Report, and more news across our portfolio.

Apr 10, 2023 •

January 2023

AlleyCorp: 2022 in Review

A look back at AlleyCorp's most active year

Jan 24, 2023 •

October 2022

AlleyCorp in Q3

New York will win, and other AlleyCorp news.

Oct 6, 2022 •

July 2022

Summer update from AlleyCorp

Announcing Impact and Robotics funds; AC team grows to 22; New incubations and investments.

Jul 27, 2022 •

May 2022

AlleyCorp in Q1

Growth across general tech, healthcare, web3, social impact, and robotics.

May 2, 2022 •

January 2022

ALLEYCORP: 2021 in Review

News on AlleyCorp's funds, founders, companies, and team.

Jan 11, 2022 •

December 2021

AlleyCorp Founder Voices: Kristin Muhlner

Kristin Muhlner is Co-Founder and CEO of Affect Therapeutics, an AlleyCorp incubation tackling substance use disorder.

Dec 6, 2021 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts